Holabird & Roche architecture firm is chosen to design ... Capacity is cut to 57,000. With a rock music booking ban in place since fans rioted in July 1970 when Sly and the Family Stone failed ...

Bedroom Three: - 3.58m x 2.38m (11'8" x 7'9") - Currently used as an impressive walk-in wardrobe and storage area ... school and church along with the historic Roche Rock within a quarter of a mile.

This past Tuesday was a bright, sunny autumn day, and I had no appointments scheduled, so I said to Nancy, “A long walk down ...

Anse La Roche in Carriacou is ... lush trees and shrubs and rugged rock formations along the shore, you’ll get Instagram-worthy pictures. And don’t miss the chance to roll down the gentle dunes or ...

The indoor atrium, designed by architect John Portman and underutilized for decades, has been revived as a green forest, complete with a sky bridge that lets guests walk above a canopy ... by Pritzker ...

Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the Swiss pharmaceutical company’s experimental obesity medicine. The poster, released as part ...

Roche Holding AG said it isn’t concerned about side effects in a small study of a weight-loss shot, after details about the trial sent shares tumbling on Monday. “We’re not alarmed at all ...

Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage trials, the pharma’s head of metabolism R&D has told Fierce Biotech.

When Roche's Genentech gained approval for Ocrevus in 2017, the first-in-class infused drug quickly became the best-selling treatment in a crowded multiple sclerosis (MS) market. Three years later ...

Swiss pharma giant Roche won approval from the Food and Drug Administration on Friday for an injectable version of its blockbuster multiple sclerosis therapy Ocrevus, cutting down the time needed ...

FRANKFURT, Sept 11 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its shares in July ...